Evaluating Hearing Loss and Cognitive Effects in Cancer Patients Receiving Platinum-Based Chemotherapy in North West England
Led by Lancaster University · Updated on 2026-09-10
172
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how platinum-based chemotherapy affects hearing in cancer patients from different socioeconomic backgrounds in the North West of England. Platinum-based drugs like cisplatin can cause permanent hearing damage, and patients from more deprived backgrounds may face higher risks due to factors like limited healthcare access and greater noise exposure. This study also explores whether hearing loss after chemotherapy is linked to changes in cognitive function, especially considering the impact of chemotherapy-related cognitive problems known as chemo brain.
Participants will undergo online hearing and cognitive tests before chemotherapy, within seven days after completing chemotherapy, and again six months later. Hearing is assessed using the Digit Triplet Test, which measures ability to understand speech in noisy environments. Cognitive function is evaluated with tests including the Flanker Test for attention and executive function, and Digit Span tasks for memory. The study will analyze how socioeconomic status, chemotherapy dose, and treatment length influence hearing loss and cognitive changes.
During the study, participants will complete short online tests at three time points to measure hearing and cognitive abilities. Researchers will monitor changes in speech reception thresholds and cognitive test scores to understand the relationships between hearing loss, cognition, and social factors. The findings aim to guide future hearing screening and support strategies for cancer patients, with assessments continuing up to six months after chemotherapy ends.
CONDITIONS
Brief Title
Chemotherapy-Induced Hearing Loss and Health Inequality
Research Team
H
Helen Nuttall
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.